Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA) has announced that its Board of Directors will convene on Thursday, 27 August 2026. The meeting’s agenda includes:
• Approval of the consolidated interim results for the six months ended 30 June 2026.
• Consideration of an interim dividend payment for the period.
The notice was signed by Chairman Yang Qiuhua on 17 August 2026 in Shanghai. Current board composition comprises four executive directors—Yang Qiuhua, Shen Bo, Li Yongzhong and Dong Ming—one non-executive director, one employee-representative director, and four independent non-executive directors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments